Publicado 20/01/2015 08:31
- Comunicado -

European Label Update of Bayer's Xarelto® Now Including Guidance for Use in Patients with Atrial Fibrillation Undergoing

Our online press service is just a click away: http://press.healthcare.bayer.com

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.


Contact:
Astrid Kranz, Tel. +49-30-468-12057
E-Mail: astrid.kranz@bayer.com

Daniela Esser, Tel. +49-30-468-15805
E-Mail: daniela.esser@bayer.com

Find more information at http://www.bayerpharma.com .

sp (2015-0002E)

Video:
http://www.multivu.com/players/uk/7421151-label-update-bayer...

Comunicados

Si quieres mejorar el posicionamiento online de tu marca, ahora puedes publicar tus notas de prensa o comunicados de empresa en la sección de Comunicados de europa press

Si necesitas asesoramiento en comunicación, redacción de tus notas de prensa o ampliar la difusión de tu comunicado más allá de la página web de europa press, ponte en contacto con nosotros en comunicacion@europapress.es o en el teléfono 913592600